172 related articles for article (PubMed ID: 38074719)
1. Can inhaled cannabis users accurately evaluate impaired driving ability? A randomized controlled trial.
Hartley S; Simon N; Cardozo B; Larabi IA; Alvarez JC
Front Public Health; 2023; 11():1234765. PubMed ID: 38074719
[TBL] [Abstract][Full Text] [Related]
2. Effect of Smoked Cannabis on Vigilance and Accident Risk Using Simulated Driving in Occasional and Chronic Users and the Pharmacokinetic-Pharmacodynamic Relationship.
Hartley S; Simon N; Larabi A; Vaugier I; Barbot F; Quera-Salva MA; Alvarez JC
Clin Chem; 2019 May; 65(5):684-693. PubMed ID: 30872375
[TBL] [Abstract][Full Text] [Related]
3. Cannabis effects on driving lateral control with and without alcohol.
Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
Drug Alcohol Depend; 2015 Sep; 154():25-37. PubMed ID: 26144593
[TBL] [Abstract][Full Text] [Related]
4. Simulated driving performance among daily and occasional cannabis users.
Brooks-Russell A; Brown T; Friedman K; Wrobel J; Schwarz J; Dooley G; Ryall KA; Steinhart B; Amioka E; Milavetz G; Sam Wang G; Kosnett MJ
Accid Anal Prev; 2021 Sep; 160():106326. PubMed ID: 34403895
[TBL] [Abstract][Full Text] [Related]
5. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
[TBL] [Abstract][Full Text] [Related]
6. A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance.
Manning B; Arkell TR; Hayley AC; Downey LA
J Psychopharmacol; 2024 Mar; 38(3):247-257. PubMed ID: 38332655
[TBL] [Abstract][Full Text] [Related]
7. The failings of
Arkell TR; Spindle TR; Kevin RC; Vandrey R; McGregor IS
Traffic Inj Prev; 2021; 22(2):102-107. PubMed ID: 33544004
[TBL] [Abstract][Full Text] [Related]
8. Driving Performance and Cannabis Users' Perception of Safety: A Randomized Clinical Trial.
Marcotte TD; Umlauf A; Grelotti DJ; Sones EG; Sobolesky PM; Smith BE; Hoffman MA; Hubbard JA; Severson J; Huestis MA; Grant I; Fitzgerald RL
JAMA Psychiatry; 2022 Mar; 79(3):201-209. PubMed ID: 35080588
[TBL] [Abstract][Full Text] [Related]
9. Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.
Bosker WM; Kuypers KP; Theunissen EL; Surinx A; Blankespoor RJ; Skopp G; Jeffery WK; Walls HC; van Leeuwen CJ; Ramaekers JG
Addiction; 2012 Oct; 107(10):1837-44. PubMed ID: 22553980
[TBL] [Abstract][Full Text] [Related]
10. [Time profile of serum THC levels in occasional and chronic marihuana smokers after acute drog use - implication for drivind motor vehicles].
Balíková M; Hložek T; Páleníček T; Tylš F; Viktorinová M; Melicher T; Androvičová R; Tomíček P; Roman M; Horáček J
Soud Lek; 2014; 59(1):2-6. PubMed ID: 24625019
[TBL] [Abstract][Full Text] [Related]
11. On the impact of cannabis consumption on traffic safety: a driving simulator study with habitual cannabis consumers.
Tank A; Tietz T; Daldrup T; Schwender H; Hellen F; Ritz-Timme S; Hartung B
Int J Legal Med; 2019 Sep; 133(5):1411-1420. PubMed ID: 30701315
[TBL] [Abstract][Full Text] [Related]
12. Cannabis smoking impairs driving performance on the simulator and real driving: a randomized, double-blind, placebo-controlled, crossover trial.
Micallef J; Dupouey J; Jouve E; Truillet R; Lacarelle B; Taillard J; Daurat A; Authié C; Blin O; Rascol O; Philip P; Mestre D
Fundam Clin Pharmacol; 2018 Oct; 32(5):558-570. PubMed ID: 29752828
[TBL] [Abstract][Full Text] [Related]
13. Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests.
Fitzgerald RL; Umlauf A; Hubbard JA; Hoffman MA; Sobolesky PM; Ellis SE; Grelotti DJ; Suhandynata RT; Huestis MA; Grant I; Marcotte TD
Clin Chem; 2023 Jul; 69(7):724-733. PubMed ID: 37228223
[TBL] [Abstract][Full Text] [Related]
14. Predicting changes in driving performance in individuals who use cannabis following acute use based on self-reported readiness to drive.
Miller R; Brown T; Schmitt R; Gaffney G; Milavetz G
Accid Anal Prev; 2024 Feb; 195():107376. PubMed ID: 37984112
[TBL] [Abstract][Full Text] [Related]
15. [Effects of oral cannabis and dronabinol on driving capacity].
Giroud C; Augsburger M; Favrat B; Menetrey A; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mathieu S; Castella V; Hazekamp A; Mangin P
Ann Pharm Fr; 2006 May; 64(3):161-72. PubMed ID: 16710114
[TBL] [Abstract][Full Text] [Related]
16. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
[TBL] [Abstract][Full Text] [Related]
17. Cannabis effects on driving longitudinal control with and without alcohol.
Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
J Appl Toxicol; 2016 Nov; 36(11):1418-29. PubMed ID: 26889769
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis: A Randomized Clinical Trial.
Marcotte TD; Umlauf A; Grelotti DJ; Sones EG; Mastropietro KF; Suhandynata RT; Huestis MA; Grant I; Fitzgerald RL
JAMA Psychiatry; 2023 Sep; 80(9):914-923. PubMed ID: 37531115
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
[TBL] [Abstract][Full Text] [Related]
20. Combined effect of alcohol and cannabis on simulated driving.
Fares A; Wickens CM; Mann RE; Di Ciano P; Wright M; Matheson J; Hasan OSM; Rehm J; George TP; Samokhvalov AV; Shuper PA; Huestis MA; Stoduto G; Brown T; Stefan C; Rubin-Kahana DS; Le Foll B; Brands B
Psychopharmacology (Berl); 2022 May; 239(5):1263-1277. PubMed ID: 33544195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
